Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs953038635
rs953038635
0.010 GeneticVariation BEFREE The Val9Ala MnSOD polymorphism does not influence ovarian cancer risk or survival. 17936883

2007

dbSNP: rs9375701
rs9375701
0.010 GeneticVariation BEFREE Meta-analyses combining the largest GWA meta-analysis data sets for these cancers totaling 112,349 cases and 116,421 controls of European ancestry, all together and in pairs, identified at P < 10(-8) seven new cross-cancer loci: three associated with susceptibility to all three cancers (rs17041869/2q13/BCL2L11; rs7937840/11q12/INCENP; rs1469713/19p13/GATAD2A), two breast and ovarian cancer risk loci (rs200182588/9q31/SMC2; rs8037137/15q26/RCCD1), and two breast and prostate cancer risk loci (rs5013329/1p34/NSUN4; rs9375701/6q23/L3MBTL3). 27432226

2016

dbSNP: rs9303542
rs9303542
0.700 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs9303542
rs9303542
G 0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010

dbSNP: rs920778
rs920778
0.020 GeneticVariation BEFREE The association between the expression of rs920778 and BC, CC, and OC susceptibility was not clear (alleles T/C: OR = 1.28 [95% CI, 0.87-1.89]; in codominant model: CT/CC OR = 1.10, [95% CI, 0.71-1.71], TT/CC OR = 1.29 [95% CI, 0.59-2.80]; dominant model: TC + TT/CC OR = 1.16, [95% CI, 0.73-1.86]; and recessive model: TT/TC + CC OR = 1.43, [95% CI, 0.83-2.47]). 30484890

2018

dbSNP: rs920778
rs920778
0.020 GeneticVariation BEFREE These findings propose that HOTAIR rs920778 polymorphism influences ovarian cancer susceptibility and prognosis, and further studies are warranted in other populations. 27690631

2017

dbSNP: rs9110
rs9110
LTF
0.010 GeneticVariation BEFREE In this study, we determined the distribution of LTF gene polymorphisms (rs1126477, rs1126478, rs2073495, and rs9110) in the Chinese Han population and investigated whether these polymorphisms were associated with increased risk of ovarian carcinoma in the Chinese. 21937479

2011

dbSNP: rs904571820
rs904571820
0.010 GeneticVariation BEFREE A direct sequencing analysis of p53 revealed a p.V173M mutation in exon 5 in both the breast tumor and the ovarian cancer. 28662703

2017

dbSNP: rs886039920
rs886039920
0.020 GeneticVariation BEFREE Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. 17220212

2007

dbSNP: rs886039920
rs886039920
0.020 GeneticVariation BEFREE The ITGB3 Leu33Pro polymorphism does not modify breast or ovarian cancer risk in BRCA1 or BRCA2 mutation carriers. 19876733

2010

dbSNP: rs879255288
rs879255288
0.010 GeneticVariation BEFREE Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer. 20437199

2010

dbSNP: rs878854066
rs878854066
0.020 GeneticVariation BEFREE Cumulative risk analysis revealed 3 unfavorable variants that increased significantly the risk of developing ovarian cancer (p.Ile1145 = ABCB1+ p.Asp1853Asn ATM+ p.Ser406Ala ATP7B- OR 7,47; p = 0,002) and significantly modified the progression free survival (PFS) of the patients, and also two favorable genotypes which protected against ovarian cancer (p.Arg952Lys ATP7B+ p.Arg72Pro TP53- OR 0,50; p = 0,008). 25591549

2015

dbSNP: rs878854066
rs878854066
0.020 GeneticVariation BEFREE Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. 21952824

2012

dbSNP: rs876660754
rs876660754
0.010 GeneticVariation BEFREE A direct sequencing analysis of p53 revealed a p.V173M mutation in exon 5 in both the breast tumor and the ovarian cancer. 28662703

2017

dbSNP: rs876660702
rs876660702
0.010 GeneticVariation BEFREE The BRCA1 G5193A mutation is too rare to contribute significantly to ovarian cancer in Iceland. 15571962

2004

dbSNP: rs876658943
rs876658943
0.010 GeneticVariation BEFREE The association between BRCA2 Arg372His polymorphism and ovarian cancer susceptibility was calculated using pooled odds ratios (ORs) appropriately derived from fixed effects models. 26111274

2015

dbSNP: rs876658657
rs876658657
0.020 GeneticVariation BEFREE These findings indicate that the -93G>A polymorphism in hMLH1 may affect ovarian cancer susceptibility in the Chinese population. 26275295

2015

dbSNP: rs876658657
rs876658657
0.020 GeneticVariation BEFREE Correction: The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population. 31150525

2019

dbSNP: rs874945
rs874945
0.010 GeneticVariation BEFREE SNPs rs12826786, rs7958904, and rs874945 did not correlate with an effect on patient susceptibility to BC, CC, and OC. 30484890

2018

dbSNP: rs873330
rs873330
0.010 GeneticVariation BEFREE We genotyped the p63 (rs873330 [Genbank, refSNP ID] T > C [T: original base, C: mutant base]) and p73 (rs4648551 G > A and rs6695978 G > A) SNPs in ovarian cancers and healthy controls and analyzed the distributions of genotype frequencies to evaluate the association of the genotypes with the risk of ovarian cancer and the clinicopathological characteristics. 23095717

2012

dbSNP: rs869312774
rs869312774
C 0.700 CausalMutation CLINVAR

dbSNP: rs869312756
rs869312756
ATM
T 0.700 GeneticVariation CLINVAR

dbSNP: rs861539
rs861539
0.030 GeneticVariation BEFREE In the subgroup analysis according to ethnicity, the results suggested that XRCC3 Thr241Met polymorphism was not associated with the risk of ovarian cancer in Caucasians population. 24254304

2014

dbSNP: rs861539
rs861539
0.030 GeneticVariation BEFREE No statistically significant associations between XRCC3 rs861539 polymorphisms and ovarian cancer risk were observed in any genetic models. 25006581

2014

dbSNP: rs861539
rs861539
0.030 GeneticVariation BEFREE The obtained results indicate that XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms may be positively associated with the incidence of ovarian carcinoma in the population of Polish women. 26801223

2016